DE69606466D1 - Verwendung eines Pulvers oder eines Extraktes von Guava zur Behandlung von Allergien - Google Patents

Verwendung eines Pulvers oder eines Extraktes von Guava zur Behandlung von Allergien

Info

Publication number
DE69606466D1
DE69606466D1 DE69606466T DE69606466T DE69606466D1 DE 69606466 D1 DE69606466 D1 DE 69606466D1 DE 69606466 T DE69606466 T DE 69606466T DE 69606466 T DE69606466 T DE 69606466T DE 69606466 D1 DE69606466 D1 DE 69606466D1
Authority
DE
Germany
Prior art keywords
guava
extract
powder
treat allergies
allergies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69606466T
Other languages
English (en)
Other versions
DE69606466T2 (de
Inventor
Sadao Hamada
Susumu Kitanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
O S Industry Co Ltd
Original Assignee
O S Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by O S Industry Co Ltd filed Critical O S Industry Co Ltd
Publication of DE69606466D1 publication Critical patent/DE69606466D1/de
Application granted granted Critical
Publication of DE69606466T2 publication Critical patent/DE69606466T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
DE69606466T 1995-06-20 1996-06-19 Verwendung eines Pulvers oder eines Extraktes von Guava zur Behandlung von Allergien Expired - Fee Related DE69606466T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7176741A JPH092969A (ja) 1995-06-20 1995-06-20 アレルギー疾患治療剤

Publications (2)

Publication Number Publication Date
DE69606466D1 true DE69606466D1 (de) 2000-03-09
DE69606466T2 DE69606466T2 (de) 2000-07-06

Family

ID=16018993

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69606466T Expired - Fee Related DE69606466T2 (de) 1995-06-20 1996-06-19 Verwendung eines Pulvers oder eines Extraktes von Guava zur Behandlung von Allergien

Country Status (4)

Country Link
US (1) US5942231A (de)
EP (1) EP0749753B1 (de)
JP (1) JPH092969A (de)
DE (1) DE69606466T2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5354833B2 (ja) * 2000-03-10 2013-11-27 株式会社ヤクルト本社 α−アミラーゼ活性阻害剤
ES2173047B1 (es) * 2001-03-21 2004-01-01 Aplicaciones Farmacodinamicas Procedimiento para la obtencion de las diferentes fracciones de guayaba atomizada y su uso para el tratamiento de la diabetes mellitus tipo ii
JP2006273843A (ja) * 2005-03-01 2006-10-12 Bizen Chemical Co Ltd シクロオキシゲナーゼ阻害剤および食用組成物
US20090004270A1 (en) * 2006-01-06 2009-01-01 Amerilab Technologies, Inc. Method of using guava extract
US7611739B2 (en) * 2006-01-06 2009-11-03 Amerilab Technologies, Inc. Method of using guava extract and composition including guava extract
KR100834850B1 (ko) * 2006-09-25 2008-06-03 주식회사 벤스랩 항알레르기성 비염, 항아토피성 피부염 또는 항만성천식 효과를 지니는 복합생약 조성물
CN102370720A (zh) * 2010-08-27 2012-03-14 翟长民 治疗鼻炎用脱敏膏
CA2823534C (en) 2010-12-28 2018-09-11 Mary Kay Inc. Topical composition comprising a psidium guajava extract and a kunzea ericoides extract for providing sebum control and treating acne
US8815308B2 (en) 2010-12-30 2014-08-26 Mary Kay, Inc. Multi-purpose cosmetic compositions
US8877259B2 (en) 2012-02-09 2014-11-04 Mary Kay Inc. Cosmetic formulation
JP6204019B2 (ja) * 2013-01-09 2017-09-27 花王株式会社 Ｃｇｉ−５８発現促進剤
EP3290031A1 (de) * 2016-08-31 2018-03-07 DSM IP Assets B.V. Verwendung von aviculin und seinen derivaten in der prävention oder behandlung von störungen der talgdrüsen
CN106139115A (zh) * 2016-09-26 2016-11-23 四川聚豪生物科技有限公司 一种治疗支气管哮喘的中药组合物及其制备方法
CN111888391B (zh) * 2020-08-13 2022-03-04 阿坝州九寨对外贸易有限公司 一种番石榴叶炮制品及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60208920A (ja) * 1984-03-01 1985-10-21 ル−ベン　ジユダ　ロビンソン 医薬物質及びその製造方法
US5066671A (en) * 1990-07-16 1991-11-19 American Home Products Corporation Ellagic acid derivatives as phospholipase A2 inhibitors
JP3193441B2 (ja) * 1992-03-09 2001-07-30 御木本製薬株式会社 美白化粧料
ES2131093T3 (es) * 1992-06-29 1999-07-16 Mortimer Tech Holdings Procedimiento de conversion de polimeros.
JP3496967B2 (ja) * 1993-12-28 2004-02-16 御木本製薬株式会社 抗プラスミン剤

Also Published As

Publication number Publication date
EP0749753A3 (de) 1997-01-02
EP0749753B1 (de) 2000-02-02
JPH092969A (ja) 1997-01-07
US5942231A (en) 1999-08-24
DE69606466T2 (de) 2000-07-06
EP0749753A2 (de) 1996-12-27

Similar Documents

Publication Publication Date Title
DE69606466D1 (de) Verwendung eines Pulvers oder eines Extraktes von Guava zur Behandlung von Allergien
ATE457170T1 (de) Verwendung eines antimikrotubulimittels zur behandlung oder vorbeugung der chirurgischen adhäsionen
DE60114580D1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
DE69622154D1 (de) Verwendung von angiogenese-suppressoren zur hemmung des haarwuchses
ATE384703T1 (de) Piperazinyl-substituierte phenylpyrimidinderivative zur behandlung oder vorbeugung von zns erkrankungen
ATE473753T1 (de) Verwendung von botulinum toxin zur behandlung von post-operative schmerzen
DE69609868D1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE69405636D1 (de) Verwendung von einem Alkylester in einer kosmetischen oder dermatologischen Zusammensetzung zur topischen Behandlung von der Hautalterung
DE60015392D1 (de) Verwendung von annexin-modulatoren zur herstellung eines medikaments zur behandlung und/oder vorbeugung von arthritis und arthritischen erkrankungen
DE69838338D1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
HK1010081A1 (en) Methods of preventing or treating allergies
DE69716251D1 (de) Verwendung von oktoxyglyzerin in einer kosmetische und/oder dermatologische zusammensetzung zur behandlung von seborrhea und akne
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen
ATE227127T1 (de) Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes
ATE332168T1 (de) Verwendung von einem polyguanidinverbindung zur behandlung oder verformung des haares, insbesondere zum wellen und glätten
DE69224173D1 (de) Behandlung von lignocellulosischen Materialien
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
ATE218862T1 (de) Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen
DE69302439D1 (de) Topisches Präparat zur Verhütung oder Behandlung der Akne Vulgaris
DE69318724D1 (de) Verwendung eines simaroubaextraktes zur verminderung von fleckiger hautpigmentierung
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE59202663D1 (de) Verwendung eines UV-Strahlers zur Behandlung von Oberflächen.
DE69601026D1 (de) Verwendung eines Antagonisten von TNF-alpha zur Behandlung von Hautrötungen neurogenen Ursprungs
DE69331833D1 (de) Verwendung von vitamin d-glykosiden zur behandlung oder prävention von osteoporose
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee